Business

Ayurvedic Herbs Market to Grow US$ 14.15 Billion by 2034, at a CAGR of 7.43% from 2026 to 2034

Ayurvedic Herbs Market to Grow US$ 14.15 Billion by 2034, at a CAGR of 7.43% from 2026 to 2034

According to the latest market analysis published by The Insight Partners, the Ayurvedic Herbs Market was valued at approximately US$ 7.42 Billion in 2025 and is projected to reach US$ 14.15 Billion by 2034, registering a CAGR of 7.43% from 2026 to 2034. The Ayurvedic Herbs Market Research study enhances the decision-making capabilities and helps … Read more

Anti-Radiation Drugs Market to Reach US$ 2.34 Billion by 2034, at a CAGR of 7.5% from 2026 to 2034

Anti-Radiation Drugs Market to Reach US$ 2.34 Billion by 2034, at a CAGR of 7.5% from 2026 to 2034

According to The Insight Partners, the Anti-Radiation Drugs market was valued at US$ 1.22 Billion in 2025 and is projected to reach US$ 2.34 Billion by 2034, registering a CAGR of 7.5% from 2026 to 2034. The Anti-Radiation Drugs Market Research study enhances the decision-making capabilities and helps to create potent counter strategies to obtain … Read more

Brain Biomarkers Market to Reach US$ 18.38 Billion by 2034, Fueled Rising Demand for Early Diagnosis

Brain Biomarkers Market to Reach US$ 18.38 Billion by 2034, Fueled Rising Demand for Early Diagnosis

According to The Insight Partners, the Brain Biomarkers Market is projected to grow from US$ 9.54 Billion in 2025 to US$ 18.38 Billion by 2034, registering a CAGR of 7.56% during the forecast period from 2026 to 2034. This consistent upward trajectory highlights the increasing clinical relevance of biomarkers in transforming neurological disease diagnosis and … Read more

Semaglutide Market Surges to US$ 64.79 Billion by 2034 at a CAGR of 10.55% from 2026 to 2034

Semaglutide Market Surges to US$ 64.79 Billion by 2034 at a CAGR of 10.55% from 2026 to 2034

According to the latest market analysis published by The Insight Partners, the Semaglutide Market was valued at approximately US$ 26.28 Billion in 2025 and is projected to reach US$ 64.79 Billion by 2034, registering a CAGR of 10.55% from 2026 to 2034. The Semaglutide Market Research study enhances the decision-making capabilities and helps to create … Read more